Rochester, NY 6/11/2009 3:09:03 AM
Late Day Losers - AMEX - Sourced WhisperFromWallStreet.com - XPL,ORS,HEB - Solitario Exploration & Royalty,XPL - Orsus Xelent Technologies Inc,ORS - Hemispherx Biopharma, Inc,HEB
Solitario Exploration & Royalty Corp. - Orsus Xelent Technologies, Inc. - Hemispherx Biopharma, Inc.
Late Day Losers - AMEX - Sourced WhisperFromWallStreet.com - XPL,ORS,HEB - Solitario Exploration & Royalty,XPL - Orsus Xelent Technologies Inc,ORS - Hemispherx Biopharma, Inc,HEB
Solitario Exploration & Royalty,XPL
Solitario Exploration & Royalty Corp., together with its subsidiaries, engages in the acquisition and exploration of mineral properties. It involves in the exploration for minerals in Latin America, focusing on precious and base metals, including gold, silver, platinum, palladium, copper, lead, and zinc. The company has eight exploration properties in Peru, Bolivia, Mexico, and Brazil; and Yanacocha and La Tola royalty interests in Peru. It has a strategic alliance with Newmont Overseas Exploration Limited to explore gold in South America. The company, formerly known as Solitario Resources Corporation, was founded in 1984 and is based in Wheat Ridge, Colorado.
Last Trade: 1.91
Day's Range: 1.91 - 2.20
52wk Range: 1.01 - 5.20
Volume: 12,500
---
Todays' investors need every available tool to stay ahead of the trends and make their moves at the proper time. If you're reading this, you are exactly the type of person who understands this. WhisperfromWallStreet.com is in tune with the market and distributes FREE alerts to our subscribers. To far in 2009 our average price gain has been 88%. If you'd to receive free alerts, sign-up now. There is not risk and you can easily track our picks and test our accuracy.
Sign up now at http://whisperfromwallstreet.com---
Orsus Xelent Technologies Inc,ORS
Orsus Xelent Technologies, Inc., together with its subsidiaries, engages in the design, manufacture, and distribution of cellular phones for retail and wholesale distribution in the People's Republic of China. It offers cell phones for Global System for Mobile communications and Code Division Multiple Access platforms. The company distributes its products through national sales distributors and dealers. Orsus Xelent Technologies, Inc. markets its products under the trademark ORSUS. The company was formerly Universal Flirts Corp. and changed its name to Orsus Xelent Technologies, Inc. in April 2005. Orsus Xelent Technologies, Inc. was founded in 2004 and is headquartered in Beijing, the People's Republic of China.
Last Trade: 1.02
Day's Range: 0.99 - 1.20
52wk Range: N/A
Volume: 742,653
---
Hemispherx Biopharma, Inc,HEB
Hemispherx Biopharma, Inc., a biopharmaceutical company, engages in the clinical development, manufacture, marketing, and distribution of new drug therapies for the treatment of viral and immune based chronic disorders. The company's products include Alferon N Injection for the treatment of genital warts; and Ampligen, an experimental drug that is in human clinical development for the treatment of myalgic encephalomyelitis/chronic fatigue syndrome, HIV, renal cell carcinoma, and malignant melanoma. Its products also comprise Alferon LDO, a low-dose, oral liquid formulation of natural alpha interferon for influenza and viral diseases, which is in the early stage of development; and Oragens for the treatment of viral diseases and disorders of the immune system. Hemispherx Biopharma, Inc. was founded in 1990 and is headquartered in Philadelphia, Pennsylvania.
Last Trade: 2.59
Day's Range: 2.48 - 2.90
52wk Range: 0.25 - 4.54
Volume: 12,387,741
---
Disclaimer: Full disclaimer at http://whisperfromwallstreet.com/disclaimer.phpWhisperfromWallStreet.com (WFWS) based upon information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by WFWS to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. WFWS is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.whisperfromwallstreet.com or mentioned herein. WFWS may have been compensated with shares or with cash from third party shareholders or the company on behalf of one or more of the companies mentioned in this opinion.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and WFWS undertakes no obligation to update such statements.
This is not a solicitation to buy or sell any securities. WhisperfromWallStreet.com, nor any of its affiliates are not registered investment advisors or a broker dealers. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.
CONTACT: WhisperFromWallStreet.com
